(Q28251676)

2

0 references

Robert B Dick

3

0 references

Julia Sitterly

4

0 references

John K Fink

5

0 references

Martha Carlson

6

0 references

Karen J Kluin

7

0 references

Matthew T Lorincz

Treatment of Wilson's disease with zinc: XV long-term follow-up studies

8

0 references

language of work or name

English

0 references

publication date

August 2009

0 references

published in

Translational Research

0 references

volume

154

0 references

issue

2

0 references

page(s)

70-7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Initial therapy of patients with Wilson's disease with tetrathiomolybdate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Copper metabolism in rats given di- or trithiomolybdates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Copper and molybdenum absorption by rats given ammonium tetrathiomolybdate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Huntington's disease in Venezuela: neurologic features and functional decline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002

Wilson's disease. Development of neurological disease after beginning penicillamine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2009.05.002